P

Inventor

VRUDHULA VIVEKANANDA M

US23 patents
⚠️ This page may combine multiple inventors who share the name “VRUDHULA VIVEKANANDA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

16 patents
US9718804B2Aug 1, 2017

GSK-3 inhibitors

BRISTOL MYERS SQUIBB CO5 citations72
US9708337B2Jul 18, 2017

Aryl amide-based kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US6888004B2May 3, 2005

Imidazolyl derivatives as corticotropin releasing factor inhibitors

BRISTOL MYERS SQUIBB CO7 citations71
US6939968B2Sep 6, 2005

Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives

BRISTOL MYERS SQUIBB CO6 citations67
US7572795B2Aug 11, 2009

Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations63
US7238699B2Jul 3, 2007

Imidazolyl derivatives as corticotropin releasing factor inhibitors

BRISTOL MYERS SQUIBB CO3 citations62
US6239146B1May 29, 2001

Neurotrophic difluoroamide agents

BRISTOL MYERS SQUIBB CO2 citations62
US6096762AAug 1, 2000

Neurotrophic difluoroamide agents

BRISTOL MYERS SQUIBB CO4 citations62
US8026257B2Sep 27, 2011

Substituted heterocyclic ethers and their use in CNS disorders

BRISTOL MYERS SQUIBB CO4 citations61
US7211669B2May 1, 2007

Imidazolyl derivatives as corticotropin releasing factor inhibitors

BRISTOL MYERS SQUIBB CO2 citations59
US8969564B2Mar 3, 2015

Aryl ether-base kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US8901305B2Dec 2, 2014

Aryl lactam kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US8703953B2Apr 22, 2014

Aryl ether-base kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US8372847B2Feb 12, 2013

Pyrazinone modulator of corticotropin-releasing factor receptor activity

BRISTOL MYERS SQUIBB CO0 citations51
US7932256B2Apr 26, 2011

(S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activity

BRISTOL MYERS SQUIBB CO0 citations51
US10035777B2Jul 31, 2018

Heterocyclic kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations41

NEORX CORP

7 patents